Objective tumor response (CR + PR) Up to 24 months [clinicaltrials_resource:96f5f9872da5b1492c6eb6d5444f41d2]
The agent would be of definite interest for further investigation if the associated response rate is at least 30% (p1), and would not be of further interest if the response rate is below 10% (p0).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Objective tumor response (CR + PR) Up to 24 months [clinicaltrials_resource:96f5f9872da5b1492c6eb6d5444f41d2]
The agent would be of definite interest for further investigation if the associated response rate is at least 30% (p1), and would not be of further interest if the response rate is below 10% (p0).
Bio2RDF identifier
96f5f9872da5b1492c6eb6d5444f41d2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:96f5f9872da5b1492c6eb6d5444f41d2
measure [clinicaltrials_vocabulary:measure]
Objective tumor response (CR + PR)
time frame [clinicaltrials_vocabulary:time-frame]
Up to 24 months
description
The agent would be of definite ...... sponse rate is below 10% (p0).
identifier
clinicaltrials_resource:96f5f9872da5b1492c6eb6d5444f41d2
title
Objective tumor response (CR + PR) Up to 24 months
@en
type
label
Objective tumor response (CR + ...... 5f9872da5b1492c6eb6d5444f41d2]
@en